These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17906484)

  • 21. Additional effects of bosentan in patients with idiopathic pulmonary arterial hypertension already treated with high-dose epoprostenol.
    Akagi S; Matsubara H; Miyaji K; Ikeda E; Dan K; Tokunaga N; Hisamatsu K; Munemasa M; Fujimoto Y; Ohe T
    Circ J; 2008 Jul; 72(7):1142-6. PubMed ID: 18577825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary arterial hypertension treated with prostacyclin or calcium blockers].
    Andreassen AK; Geiran O; Madsen S; Hognestad A; Simonsen S
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3393-6. PubMed ID: 14713978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
    Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
    J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension.
    Hirabayashi A; Miyaji K; Akagi T
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):688-91. PubMed ID: 19133673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of severe pulmonary hypertension associated with COPD treated with epoprostenol].
    Ishikawa S; Yano S; Wakabayashi K; Tokuda Y; Kobayashi K; Ikeda T; Takeyama H
    Nihon Kokyuki Gakkai Zasshi; 2008 Aug; 46(8):660-6. PubMed ID: 18788437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
    Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterotopic heart transplantation for elevated pulmonary vascular resistance in pediatric patients.
    Cochrane AD; Adams DH; Radley-Smith R; Khaghani A; Yacoub MH
    J Heart Lung Transplant; 1995; 14(2):296-301. PubMed ID: 7779849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
    Sitbon O; McLaughlin VV; Badesch DB; Barst RJ; Black C; Galiè N; Humbert M; Rainisio M; Rubin LJ; Simonneau G
    Thorax; 2005 Dec; 60(12):1025-30. PubMed ID: 16055621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary artery hypertension in heart transplant recipients: how much is too much?
    De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful cardiac transplantation in a patient with elevated pulmonary vascular resistance: a relative contraindication to transplantation.
    Morris CD; Smith RD; Kar B; Ghodsizad A; Reverdin S; Frazier OH; Gregoric ID
    Heart Surg Forum; 2009 Jan; 12(1):E59-60. PubMed ID: 19233769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.
    St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891
    [No Abstract]   [Full Text] [Related]  

  • 34. Up-front combination therapy in pulmonary arterial hypertension: from clinical trials to 'real world' observational studies.
    Grignola JC
    Int J Cardiol; 2014 May; 173(3):349-50. PubMed ID: 24698227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making.
    Mikus E; Stepanenko A; Krabatsch T; Dandel M; Lehmkuhl HB; Loforte A; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Mar; 39(3):310-6. PubMed ID: 20615720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 37. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
    Dietrich CG; Gartung C; Siewert E; Lammert F; Matern S; Geier A
    Z Gastroenterol; 2006 Jan; 44(1):33-7. PubMed ID: 16397837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epoprostenol treatment in children with severe pulmonary hypertension.
    Lammers AE; Hislop AA; Flynn Y; Haworth SG
    Heart; 2007 Jun; 93(6):739-43. PubMed ID: 17065181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
    Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.